Atorvastatin Calcium
Product Images NDC 82239-004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82239-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by August Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-10mg-01 (Atorvastatin 10mg 01)

FDA Label Image

Atorvastatin-10mg-02 (Atorvastatin 10mg 02)

Atorvastatin-10mg-02 (Atorvastatin 10mg 02)
This is a description of a medication called Atorvastatin Calcium Tablets, with each tablet containing 10mg of atorvastatin. Dosage and use instructions are available in the package insert. The tablets should be stored at room temperature and dispensed in a tight container. The medication is manufactured by Halo Pharmaceutical in Canada and distributed by August Pharmaceutical in the US. The NDC number is 82239-001-02 and lot exp is not available.*
FDA Label Image

Atorvastatin-10mg-04 (Atorvastatin 10mg 04)

Atorvastatin-10mg-04 (Atorvastatin 10mg 04)
This is a description for Atorvastatin calcium tablets, USP. Each film-coated tablet contains 10mg atorvastatin calcium. The NDC number for this product is 82239-001-04, and the expiry date is 09/2021. This medication should be stored at a controlled room temperature of 20-25°C (68-77°F). It is recommended to dispense it in light containers, and the full prescribing information can be found on the package insert. The manufacturer is Halo Pharmaceutical Canada, Inc, and it is distributed by August Pharmaceutical, LLC. The Lot number and expiry date details are not available.*
FDA Label Image

Atorvastatin-10mg-3 (Atorvastatin 10mg 3)

Atorvastatin-10mg-3 (Atorvastatin 10mg 3)
Each film-coated tablet contains 10 mg atorvastatin. It is recommended to see the package insert for complete prescribing information. Store at room temperature between 20-25°C (68-77°F). It should be dispensed in tight containers. The manufacturing has been done by Halo Pharmaceutical Canada, Inc. It comes with 500 tablets and is only available through a prescription (Rx only). The Lot and Exp details are not available.*
FDA Label Image

Atorvastatin-20mg-01 (Atorvastatin 20mg 01)

Atorvastatin-20mg-01 (Atorvastatin 20mg 01)
This is a description of Atorvastatin Calcium Tablets, USP, which is a medication used to lower cholesterol levels. Each labeled tablet contains 20 mg of atorvastatin calcium. The recommended dosage and usage information can be found in the package insert. The medication should be stored at a controlled room temperature of 20-25°C and dispensed in tight containers. The tablets are manufactured by Halo Pharmaceutical Canada, Inc., with an NDC 82239-002-02, and distributed by August Pharmaceutical, LLC from Fairfield, NJ. Prescription is required to obtain the medication.*
FDA Label Image

Atorvastatin-20mg-04 (Atorvastatin 20mg 04)

Atorvastatin-20mg-04 (Atorvastatin 20mg 04)
Atorvastatin Calcium Tablets are film-coated and contain 20 mg of alorvastalin calcium, USP. The package includes 1000 tablets and must be stored in a controlled room at 20-25°C (68-77°F). The product information is provided in the package insert, and the tablets must be dispensed in tight containers. The manufacturer of this product is Halo Pharmaceutical Canada, Inc, and it has been distributed by August Pharmaceutical, LLC. The lot number and expiration date can be found on the package.*
FDA Label Image

Atorvastatin-20mg-1 (Atorvastatin 20mg 1)

Atorvastatin-20mg-1 (Atorvastatin 20mg 1)
Atorvastatin calcium tablets are a prescription medication used to lower cholesterol levels in the blood. Each tablet contains 20 mg of atorvastatin and should be stored at a controlled room temperature. Full prescribing information can be found in the package insert. The tablets are manufactured by Halo Pharmaceutical Canada, Inc and distributed by August Pharmaceutical, LLC. The batch information for this set of tablets is not available (marked by "Exp:").*
FDA Label Image

Atorvastatin-20mg-03 (Atorvastatin 20mg 3)

Atorvastatin-20mg-03 (Atorvastatin 20mg 3)
This is a description for a medication called AtorvaStatm which comes in film-coaled lablets with 20mg of atorvastatin calcium. Each lablet has the NDC code 82239-002-03 and an expiration date of 09/2021. The full prescribing information can be found in the package insert. The medication should be stored at a controlled room temperature of 20-25°C (68-77°F) and dispensed in tight containers. It comes in a bottle containing 500 tablets and can only be prescribed by a doctor. This medication is manufactured by Halo Pharmaceutical Canada, Inc.*
FDA Label Image

Atorvastatin-40mg-01 (Atorvastatin 40mg 01)

Atorvastatin-40mg-01 (Atorvastatin 40mg 01)
This is a description of a medication called Atorvastatin Calcium Tablets. Each tablet contains 40mg of atorvastatin. The dosage and usage information can be found in the package insert. The tablets should be stored at room temperature and dispensed in tight containers. They are manufactured by Halo Pharmaceutical Canada, Inc and distributed by August Pharmaceutical, LLC. The NDC number is 82239-003-01. The medication is only available by prescription and the lot and expiration date are provided.*
FDA Label Image

Atorvastatin-40mg-02 (Atorvastatin 40mg 02)

Atorvastatin-40mg-02 (Atorvastatin 40mg 02)
This is a description of a medication called Atorvastatin Calcium, USP, in a specific dosage of 40mg, and packaged in film-coated tablets. The medication is intended for prescription use only and is manufactured by Halo Pharmaceutical Canada, Inc, with packaging and distribution by August Pharmaceutical, LLC. The product's lot number and expiration date are not provided in the text. The user is advised to refer to the package insert for complete dosage and usage information, and store the medication at a controlled room temperature. The medication should be dispensed in tight containers.*
FDA Label Image

Atorvastatin-40mg-03 (Atorvastatin 40mg 03)

Atorvastatin-40mg-03 (Atorvastatin 40mg 03)
Each tablet contains 40 mg of alorvastatin calcium and the package insert should be consulted for full prescribing information. The tablets should be stored at a controlled temperature of 20-25°C and be dispensed in tight containers. Manufactured by Halo Pharmaceutical Canada Inc, and distributed by August Pharmaceutical LLC, the tablets come in a bottle of 500 and are available only with a prescription. Lot number and expiration date are not available.*
FDA Label Image

Atorvastatin-40mg-04 (Atorvastatin 40mg 04)

Atorvastatin-40mg-04 (Atorvastatin 40mg 04)
Atorvastatin Calcium Tablets, USP are a medication that comes in film-coated form, with each tablet containing 40 mg of atorvastatin calcium. Information on how to use and dose this medication is available in the package insert, and it should be stored in a controlled environment at a temperature of 20-25°C. It must also be dispensed in tightly sealed containers following USP guidelines. These tablets are manufactured by Halo Pharmaceutical Canada, Inc, and available in containers of 1000 tablets. It's an RX-only medication provided by August Pharmaceutical, LLC, having the NDC 82239-003-04. The lot number of the medicine, along with its expiry date, is also mentioned.*
FDA Label Image

Atorvastatin-80mg-01 (Atorvastatin 80mg 01)

Atorvastatin-80mg-01 (Atorvastatin 80mg 01)
This is a medication called Atorvastatin Calcium Tablets, USP in a dosage of 80 mg per film-coated tablet. The tablets should be stored at a controlled room temperature and should be dispensed in tight containers. The manufacturer is Halo Pharmaceutical Canada, Inc and the product is distributed by August Pharmaceutical, LLC. The NDC number is 82239-004-01. Please refer to the package insert for full prescribing information. Specific information about dosage, usage, and expiration date is not available.*
FDA Label Image

Atorvastatin-80mg-02 (Atorvastatin 80mg 02)

Atorvastatin-80mg-02 (Atorvastatin 80mg 02)
Each film-coated tablet contains 80 mg atorvastatin calcium, for which the complete prescribing information is available in the package insert. The tablets should be stored at 20-25°C (68-77°F) and dispensed in tight containers. They were manufactured by Halo Pharmaceutical Canada, Inc and distributed by August Pharmaceutical, LLC. The product contains 90 tablets and has the NDC number 82239-004-02. The lot number and expiration date are not available in the given text.*
FDA Label Image

Atorvastatin-80mg-03 (Atorvastatin 80mg 03)

FDA Label Image

Atorvastatin-80mg-04 (Atorvastatin 80mg 04)

Atorvastatin-80mg-04 (Atorvastatin 80mg 04)
This is a medication called Atorvastatin Calcium Tablets, USP that comes in a film-coated tablet form with a strength of 80 mg. The tablets are packaged in a tight container and the full prescribing information can be found in the package insert. The manufacturer is Halo Pharmaceutical Canada, Inc. The provided text displays lot and expiration date information.*
FDA Label Image

Atorvastatin-fi1-jpg.jpg (Atorvastatin Fi1 Jpg)

FDA Label Image

Atorvastatin-fi2-jpg.jpg (Atorvastatin Fi2 Jpg)

Atorvastatin-fi2-jpg.jpg (Atorvastatin Fi2 Jpg)
This appears to be a graph depicting the cumulative hazard (%) and hazard ratio (HR) for a primary endpoint over a period of four years. The HR value is reported as 0.63 with a confidence interval of 0.48-0.83 and a significance value (p) of 0.001. The x-axis represents the time (in years) to the first primary endpoint. No further information is available to determine the specifics of the primary endpoint being studied.*
FDA Label Image

Atorvastatin-fig3-jpg.jpg (Atorvastatin Fig3 Jpg)

Atorvastatin-fig3-jpg.jpg (Atorvastatin Fig3 Jpg)
The text describes the percentage of subjects experiencing a cardiovascular event while taking either 10mg or 80mg of Atorvastatin. The data is presented in a graph showing the time to the first major cardiovascular endpoint in years. There is also a statistical analysis indicating a significant difference between the two dosages.*
FDA Label Image

Atorvastatin-structure (Atorvastatin Molstructure Jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.